We use cookies. Find out more about it here. By continuing to browse this site you are agreeing to our use of cookies.
#alert
Back to search results
New

Vice President, Clinical Products

Blue Shield of CA
United States, California, Long Beach
3840 Kilroy Airport Way (Show on map)
Nov 17, 2026

The Vice President, Clinical Products is accountable for the clinical product portfolio, which spans Physical Health, including Oncology, Cardio-Kidney-Metabolic Health, Musculoskeletal Health, and Women's Health, as well as Behavioral Health and future priority conditions and populations, across Commercial, Medicare, Medi-Cal, and self-funded business.

The role is a central component of HQA's one-year Annual Plan, three-year strategy, and ten-year strategic plan. The Vice President shapes how Blue Shield will deliver care for its highest-cost, highest-impact conditions over the next decade, translates that long-term direction into multi-year roadmaps, annual operating plans, and month-over-month performance, and will contribute significantly to Blue Shield's annual affordability goal.

The Vice President holds end-to-end accountability for every clinical product, including product strategy, the evidence-based clinical model, clinical outcomes, affordability, quality, safety, equity, adoption, member and provider experience, and financial performance. The executive will establish Oncology as the flagship clinical product and the first proof point of the operating model, then scale the model across the portfolio.

Clinical informatics for clinical decision-making is core to the role. The Vice President sets the enterprise approach for clinical outcome measurement, decision support, automation, and a common measurement framework, and provides clinical direction to analytics teams across Blue Shield rather than owning all analytics. The executive will partner with Stellarus, within Blue Shield's Family of Companies, to enable a clinical intelligence layer that brings clinical insight into decisions across the enterprise.

The Vice President will play a critical role in advancing provider partnerships and piloting new care and payment models, scaling those that improve outcomes and affordability. The role will partner closely with Pharmacy to integrate specialty therapeutics under the Medical Benefit into appropriate clinical products. The Vice President will also move Blue Shield to proactive intervention at scale, building products that harness connected data and intelligence to predict risk earlier, coordinate care and intercept disease sooner, personalize evidence-based interventions, and continuously learn and improve.

The function is deliberately lean. The Vice President mobilizes clinical, provider, network, pharmacy, actuarial, operational, financial, technology, and analytic expertise across the enterprise and the Family of Companies around shared product outcomes, supported by and enablement team. The scope of this role is defined by the required clinical and analytic expertise, the enterprise strategy it shapes, the clinical products it delivers, and the medical spend it influences.

Success will be measured by a significant contribution to Blue Shield's annual outcomes, affordability, and growth goals, including improving our members' health trajectory by anticipating risk, preventing disease progression, and achieving improved and equitable outcomes; structurally addressing affordability by lowering the cost of healthcare and evolving how we operate; and creating sustainable, integrated provider partnerships through an evolved and differentiated operating model. Success will also be measured by the launch and performance of Oncology as the flagship product; adoption of a common clinical outcomes framework across all clinical domains; disciplined delivery against annual, three-year, and ten-year objectives; and recognition of Blue Shield as a national leader in outcomes-based clinical product management.

The Vice President, Clinical Products is Blue Shield's senior physician executive for clinical products. Reporting to the EVP, Healthcare Quality and Affordability, in close partnership with the Chief Medical Officer and the Senior Vice President, Network, this executive serves as a senior clinical advisor to the executive leadership team and the Board of Directors. The role carries decision authority, exercised through shared decision rights with executive peers in Blue Shield's enterprise governance, consistent with how the organization makes its most consequential clinical and financial decisions.

Our leadership model is about developing great leaders at all levels and creating opportunities for our people to grow - personally, professionally, and financially. We are looking for leaders that are energized by creative and critical thinking, building and sustaining high-performing teams, getting results the right way, and fostering continuous learning.

Your Knowledge and Experience

  • Doctor of Medicine (MD) or Doctor of Osteopathic Medicine (DO).

  • Active license to practice medicine in the United States; California licensure or eligibility preferred.

  • 15+ years of progressive physician leadership experience spanning clinical practice and executive roles in health plans, integrated delivery systems, and/or provider organizations.

  • Deep expertise in clinical informatics and clinical analytics, including outcomes measurement, intervention and program evaluation, longitudinal claims and clinical data, risk stratification, and clinical decision support; board certification in Clinical Informatics or equivalent advanced training strongly preferred.

Demonstrated Experience

  • Leadership experience with accountability for clinical strategy, clinical products, medical cost, and/or quality outcomes.
  • Board certification in a clinical specialty.
  • Demonstrated success using data, analytics, and artificial intelligence to change clinical decisions and produce measurable improvements in outcomes and total cost of care.
  • Executive accountability for a major clinical portfolio, service line, population, or medical cost category, with measurable clinical and financial results at enterprise scale.
  • Demonstrated success shaping multi-year enterprise strategy and translating it into operating models, annual plans, and measurable results.
  • Experience advising executive leadership teams and Boards of Directors on clinical strategy, investment, performance, and risk.
  • Deep knowledge of healthcare economics, value-based payment, provider performance, medical management, and the health plan regulatory and accreditation environment, including CMS, DMHC, and NCQA.
  • Demonstrated ability to lead through influence in complex, highly matrixed organizations, aligning clinical, operational, financial, and technology leaders around shared outcomes.
  • A national clinical reputation and credibility with physicians, health system executives, and industry peers, demonstrated through leadership, publications, or national advisory roles.
  • Experience in Oncology or another complex, high-cost clinical service line; Oncology experience strongly preferred.
  • Experience designing and evaluating provider partnerships and pilots that test new care and payment models.
  • Experience with Specialty Pharmacy, specialty therapeutics, site-of-care strategy, or other high-cost clinical categories.
  • Advanced degree in business, public health, health administration, or informatics (MBA, MPH, MHA, or MS) preferred.
  • Demonstrated ability to set a ten-year clinical vision while driving disciplined month-over-month execution.
Applied = 0

(web-7dc44f465b-g5dzf)